newsfilter
← Latest News
GlobeNewswire·

ObsEva Appoints Katja Buhrer as Chief Strategy Officer

GENEVA, Feb. 01, 2022 (GLOBE NEWSWIRE) -- ObsEva SA (NASDAQ:OBSV, SIX: OBSN))), a biopharmaceutical company developing and commercializing novel therapies for women's health, today announced the appointment of Katja Buhrer as Chief Strategy Officer and